基于“异病同治”探讨“从脾论治”高脂血症及动脉粥样硬化共同理论基础及临床应用  

Common Theoretical Basis and Clinical Application of “Treating Hyperlipemia and Atherosclerosis from Spleen Theory” Based on Theory“Treating Different Diseases with the Same Rule”

作　　者：陈丝 杨关林[1] 王群[1] 宋囡[1] 贾连群[1,2] CHEN Si;YANG Guanlin;WANG Qun;SONG Nan;JIA Lianqun(Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications of Liaoning University of Traditional Chinese Medicine,Translational Medicine Research Center of Traditional Chinese Medicine in Liaoning,Shenyang 110847,Liaoning,China;Liaoning University of Traditional Chinese Medicine,Shenyang 110847,Liaoning,China)

机构地区：[1]辽宁中医药大学中医脏象理论及应用教育部重点实验室,辽宁沈阳110847 [2]辽宁省中医转化医学研究中心,辽宁沈阳110847

出　　处：《中华中医药学刊》2018年第9期2200-2202,共3页Chinese Archives of Traditional Chinese Medicine

基　　金：国家自然科学基金项目(81774022);辽宁省“百千万人才工程”项目(2017-58);辽宁省高等学校创新团队支持计划项目(LT2016012)

摘　　要：＂异病同治＂是辨证论治理论的经典应用之一,对病机大致相同的不同疾病有较好的临床疗效;脾是人体内重要脏腑之一,称为后天之本,气血生化之源,在体主运化,主统血,脾失健运,功能失常是多种疾病的病理基础。课题组前期研究发现脾虚运化功能失常是导致血脂异常的关键病机,同时发现脾失健运膏脂转输障碍与动脉粥样硬化发生关系密切,基于＂异病同治＂探讨＂从脾论治＂高脂血症及动脉粥样硬化共同理论基础。＂Treating different diseases with the same rule＂is one of the classical applications of the theory of syndrome differentiation and treatment,and has a good clinical effect on different diseases with the same pathogenesis.Spleen is one of the important internal organs of the human body,known as the foundation of acquired constitution,the source of Qi and blood. Spleen governing transportation and transformation,dominating blood circulation,and the dysfunction of the spleenis the pathological basis of a variety of diseases. Research group found that the dysfunction of the spleen is the key pathogenesis leading to dyslipidemia,and dysfunction of spleen in transportation and atherosclerosis is closely related. This articlebased on the theory of ＂treating different diseases with the same rule＂exploredthe common theoretical basis of ＂treating hyperlipemia and atherosclerosis with the spleen theory＂.

关 键 词：异病同治 从脾论治 动脉粥样硬化 高脂血症 

分 类 号：R589.2[医药卫生—内分泌] R541.4[医药卫生—内科学]